Buy Lucius Sparsentan online
This drug received accelerated approval from the U.S. FDA in February 2023. It targets the endothelin A receptor (ETAR) and angiotensin II 1 receptor (AT1R) and is a prescription drug that should be used only as directed by a doctor.
View Product